Just – Evotec Signs a Development and Manufacturing Agreement with OncoResponse for OR2805

 Just – Evotec Signs a Development and Manufacturing Agreement with OncoResponse for OR2805

Just – Evotec Signs a Development and Manufacturing Agreement with OncoResponse for OR2805

Shots:

  • Just-Evotec to leverage its technology platform, J.Design to accelerate OncoResponse’s OR2805 through the development and into the clinic
  • Just-Evotec provides services to the OncoResponse which includes cell line development, process development, and P-I/II cGMP clinical manufacturing of OR2805 in human clinical studies
  • OncoResponse’s OR2805 is an Ab, reversing the immunosuppression in the tumor microenvironment and promoting cancer-killing, leading to higher response rates

Click here ­to­ read full press release/ article | Ref: Evotec | Image: Canaan

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post